DuPont de Nemours is an advanced solutions provider focused on healthcare, water, construction, and industrial end markets. The company has subsidiaries in approximately 50 countries and manufacturing operations in approximately 20 countries as of December 31, 2025. Following a multi-year portfolio transformation — including the 2019 spin-offs of Dow and Corteva, the 2021 divestiture of Nutrition & Biosciences to IFF, the 2022 divestiture of the Materials & Mobility segment to Celanese, and the November 2025 separation of the Electronics Business as Qnity Electronics — DuPont has narrowed to specialty applications in clean water, medical packaging, and related industrial markets.
DuPont entered a definitive agreement in the third quarter of 2025 to sell its Aramids business to Arclin, a transaction expected to close around the end of the first quarter of 2026. The company's remaining operations are oriented toward helping customers advance technology pipelines in its target end markets. Revenues and certain expenses associated with the M&M Businesses, Aramids Business, and Electronics Business are classified as discontinued operations in current and historical financial reporting periods.
Diversified Industrials 53% · Healthcare And Water Technologies 47%
business segments · FY2025 (ended Dec 2025) · share of tagged segment revenue (10-K XBRL, as filed)
